Prime Medicine, Inc. Common Stock (PRME) stock news · rev $4.6M
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
This PRME news page leads with what Prime Medicine, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for PRME yet. We will not pad this page with generic market recap.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PRME stock page; for the tape open the quote page.
PRME stock news FAQ
What are PRME's latest revenue and net income?
Latest cached Prime Medicine, Inc. Common Stock (PRME) revenue for Dec 31, 2025 was $4.6M. Net income was -$201.1M. Statements: https://lician.com/financials/prme
How did PRME revenue change from the prior cached period?
Cached Prime Medicine, Inc. Common Stock (PRME) revenue was up 55.3% from $3.0M (Dec 31, 2024) to $4.6M (Dec 31, 2025). Statements: https://lician.com/financials/prme
What is PRME's market cap?
Prime Medicine, Inc. Common Stock (PRME) market cap is $570.8M on the latest cached fundamentals snapshot.
What kind of company is PRME?
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Where is PRME stock news listed?
Cached stock news for Prime Medicine, Inc. Common Stock (PRME) is listed at https://lician.com/news/prme. Filings: https://lician.com/sec/prme
Not investment advice.